Review



eclipse dualtec af4 separation system  (Waters Corporation)


Bioz Manufacturer Symbol Waters Corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Waters Corporation eclipse dualtec af4 separation system
    Eclipse Dualtec Af4 Separation System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 200 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eclipse dualtec af4 separation system/product/Waters Corporation
    Average 93 stars, based on 200 article reviews
    eclipse dualtec af4 separation system - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    Waters Corporation eclipse dualtec af4 separation system
    Eclipse Dualtec Af4 Separation System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eclipse dualtec af4 separation system/product/Waters Corporation
    Average 93 stars, based on 1 article reviews
    eclipse dualtec af4 separation system - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Waters Corporation eclipse dualtec separation system
    Eclipse Dualtec Separation System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eclipse dualtec separation system/product/Waters Corporation
    Average 93 stars, based on 1 article reviews
    eclipse dualtec separation system - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Waters Corporation eclipse dualtec separation module
    Eclipse Dualtec Separation Module, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eclipse dualtec separation module/product/Waters Corporation
    Average 93 stars, based on 1 article reviews
    eclipse dualtec separation module - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Waters Corporation asymmetric flow field flow fractionation af4 eclipse dualtec separation system
    Asymmetric Flow Field Flow Fractionation Af4 Eclipse Dualtec Separation System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/asymmetric flow field flow fractionation af4 eclipse dualtec separation system/product/Waters Corporation
    Average 93 stars, based on 1 article reviews
    asymmetric flow field flow fractionation af4 eclipse dualtec separation system - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Waters Corporation eclipse dualtec a4f separation system
    Figure 2. The bispecific arms of R3-Altibody form cis complexes with FGFR3-ECD. A, HDX epitope mapping shows that Ab1 (Fab component of R3-Altibody) interacts with Ig-like domain 3, whereas Ab3 (N-term scFv component of R3-Altibody) interacts with Ig-like domain 1. Magenta, peptides that showed differences in deuterium uptake ΔD% ≥ 25%; blue, 25% >ΔD ≥ 20%. Structure of FGFR3 D2–D3 was adopted from PDB 1RY7, model of FGFR3 D1 was adopted from AlphaFold structure prediction (AF-P22607-F1- model_v4). B, R3-Altibody predominantly forms a 1:2 complex (calculated molecular weight 302 kDa) with monomeric FGFR3b-ECD when mixed at 1:2 µmol/L ratio (left). The molar masses of free FGFR3-ECD, R3-Altibody, and R3-Altibody in complex with FGFR3b-ECD were determined by <t>A4F-MALS.</t> The experimentally determined molar masses are indicated by horizon lines. Left, two models of the 1:2 complex are depicted as cis vs. trans binding. Right, the molar masses of the free FGFR3-ECD, scFv-Fab arm from R3-Altibody, and the scFv-Fab arm in complex with FGFR3b-ECD were determined by SEC-MALS. The chromatograms show traces representing scFv-Fab:hFGFR3b- ECD mixed at ratios of 1:3 (green), 1:1 (red), and 3:1 (blue). Molecular mass and pictogram of free scFv-Fab, FGFR3b-ECD, and the complex of scFv-Fab bound to FGFR3-ECD are shown above the corresponding peaks. The minor species of ∼247 kDa is consistent with a 1:2 complex (in cis mode) between residual unreduced 2 + 2 (scFv-Fabʹ)2 in our preparation and FGFR3b-ECD. (A, Created with PyMOL.)
    Eclipse Dualtec A4f Separation System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eclipse dualtec a4f separation system/product/Waters Corporation
    Average 93 stars, based on 1 article reviews
    eclipse dualtec a4f separation system - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. The bispecific arms of R3-Altibody form cis complexes with FGFR3-ECD. A, HDX epitope mapping shows that Ab1 (Fab component of R3-Altibody) interacts with Ig-like domain 3, whereas Ab3 (N-term scFv component of R3-Altibody) interacts with Ig-like domain 1. Magenta, peptides that showed differences in deuterium uptake ΔD% ≥ 25%; blue, 25% >ΔD ≥ 20%. Structure of FGFR3 D2–D3 was adopted from PDB 1RY7, model of FGFR3 D1 was adopted from AlphaFold structure prediction (AF-P22607-F1- model_v4). B, R3-Altibody predominantly forms a 1:2 complex (calculated molecular weight 302 kDa) with monomeric FGFR3b-ECD when mixed at 1:2 µmol/L ratio (left). The molar masses of free FGFR3-ECD, R3-Altibody, and R3-Altibody in complex with FGFR3b-ECD were determined by A4F-MALS. The experimentally determined molar masses are indicated by horizon lines. Left, two models of the 1:2 complex are depicted as cis vs. trans binding. Right, the molar masses of the free FGFR3-ECD, scFv-Fab arm from R3-Altibody, and the scFv-Fab arm in complex with FGFR3b-ECD were determined by SEC-MALS. The chromatograms show traces representing scFv-Fab:hFGFR3b- ECD mixed at ratios of 1:3 (green), 1:1 (red), and 3:1 (blue). Molecular mass and pictogram of free scFv-Fab, FGFR3b-ECD, and the complex of scFv-Fab bound to FGFR3-ECD are shown above the corresponding peaks. The minor species of ∼247 kDa is consistent with a 1:2 complex (in cis mode) between residual unreduced 2 + 2 (scFv-Fabʹ)2 in our preparation and FGFR3b-ECD. (A, Created with PyMOL.)

    Journal: Cancer Research

    Article Title: A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants

    doi: 10.1158/0008-5472.can-23-3195

    Figure Lengend Snippet: Figure 2. The bispecific arms of R3-Altibody form cis complexes with FGFR3-ECD. A, HDX epitope mapping shows that Ab1 (Fab component of R3-Altibody) interacts with Ig-like domain 3, whereas Ab3 (N-term scFv component of R3-Altibody) interacts with Ig-like domain 1. Magenta, peptides that showed differences in deuterium uptake ΔD% ≥ 25%; blue, 25% >ΔD ≥ 20%. Structure of FGFR3 D2–D3 was adopted from PDB 1RY7, model of FGFR3 D1 was adopted from AlphaFold structure prediction (AF-P22607-F1- model_v4). B, R3-Altibody predominantly forms a 1:2 complex (calculated molecular weight 302 kDa) with monomeric FGFR3b-ECD when mixed at 1:2 µmol/L ratio (left). The molar masses of free FGFR3-ECD, R3-Altibody, and R3-Altibody in complex with FGFR3b-ECD were determined by A4F-MALS. The experimentally determined molar masses are indicated by horizon lines. Left, two models of the 1:2 complex are depicted as cis vs. trans binding. Right, the molar masses of the free FGFR3-ECD, scFv-Fab arm from R3-Altibody, and the scFv-Fab arm in complex with FGFR3b-ECD were determined by SEC-MALS. The chromatograms show traces representing scFv-Fab:hFGFR3b- ECD mixed at ratios of 1:3 (green), 1:1 (red), and 3:1 (blue). Molecular mass and pictogram of free scFv-Fab, FGFR3b-ECD, and the complex of scFv-Fab bound to FGFR3-ECD are shown above the corresponding peaks. The minor species of ∼247 kDa is consistent with a 1:2 complex (in cis mode) between residual unreduced 2 + 2 (scFv-Fabʹ)2 in our preparation and FGFR3b-ECD. (A, Created with PyMOL.)

    Article Snippet: All samples were incubated at ambient temperature for 2170 Cancer Res; 84(13) July 1, 2024 CANCER RESEARCH ow nloaded from http://aacrjournals.org/cancerres/article-pdf/84/13/2169/3469387/can-23-3195.pdf by guest on 13 Septem ber 2024 2 hours and injected into an Eclipse DualTec A4F separation system coupled to an Agilent 1200 HPLC with DAWN laser light scattering instrument and an Optilab T-rEX differential refractometer detector (Wyatt Technology).

    Techniques: Molecular Weight, Binding Assay